Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SOWAHCP5 stands for "Sosondowah ankyrin repeat domain family member C pseudogene 5." It is annotated as a pseudogene, meaning it is a DNA sequence resembling a gene but typically non-functional—it does not encode a functional protein due to disruptions in the sequence such as frame-shifts or premature stop codons. No scientific evidence currently supports a functional role for SOWAHCP5 in physiological or pathological processes, and it is not documented as a therapeutic target or functional receptor/enzyme/transporter. There is, however, a related *protein-coding gene* named **SOWAHC** (sosondowah ankyrin repeat domain family member C, also known as ANKRD57), which has been discussed as a potential prognostic biomarker in cancer, but this is a separate entity from the SOWAHCP5 pseudogene[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sosondowah ankyrin repeat domain family member C pseudogene 5 (SOWAHCP5).